Back to 13F data
Unclassified

BIONTECH SE

BIONTECH SE is tracked here as a normalized 13F company record; no curated business description is available yet.

Original CUSIPs: 09075V102. This page shows current managers, quarterly changes, and primary SEC sources.

Current managers
1
Latest reporting quarter
Q1 2026

Who holds it and what changed this quarter

Portfolio weight and share-count changes are shown for every tracked manager with a current or prior-quarter position.

ARK Invest
Cathie Wood
Q1 2026
New position
New position: 0.09%

ARK Invest opened a new position at 0.09% of the portfolio, buying 127,878 shares.

+127,878 Shares
n/a
SEC05/12/2026
Bridgewater Associates
Ray Dalio / Bridgewater
Q1 2026
Exited
Exited: 0.00%

Bridgewater Associates exited a position that was 0.00% of the portfolio, selling 4,927 shares.

-4,927 Shares
-100.00%
SEC05/15/2026

Four-quarter trend

Each line is one tracked manager’s portfolio weight. Labels identify the manager directly.

Historical and source details

Market values, quarterly totals, and original CUSIP rows are available below without obscuring current actions.

Quarterly holdings details
QuarterCurrent managersCombined valueTotal sharesManager details
Q2 20250$00
Q3 20250$00
Q4 20251$469,0504,927
Bridgewater Associates New position · 4,927 Shares
Q1 20261$11,365,812127,878
Bridgewater Associates Exited · 0 Shares
ARK Invest New position · 127,878 Shares
Original CUSIP details
ManagerIssuerCUSIPSecurity classMarket valueSharesWeightSource
ARK InvestBioNTech SE09075V102ADR$11,365,812127,8780.09%SEC XML